About
Cleerly develops AI-powered software that analyzes cardiac CT scans to quantify and characterize coronary artery disease, including both calcified and non-calcified plaque. Their platform provides a detailed “Cleerly Score” assessing overall cardiac risk, moving beyond traditional stenosis-based assessments. This technology targets cardiologists and health systems seeking more precise and comprehensive early detection of heart disease to enable preventative interventions.
Focus Areas
Technology Focus
healthcare computer vision ml infrastructure
Quick Stats
Total Raised $223M
Founded 2017
Status private
Type scaleup
Explore More
Similar Companies
Viz.ai
San Francisco, United States
82%
3 shared categories
3 shared AI types
Same country
Healthcare AIAI Research +1
Arterys
San Francisco, United States
82%
3 shared categories
3 shared AI types
Same country
Healthcare AIAI Research +1
Aidoc
Tel Aviv, Israel
75%
3 shared categories
3 shared AI types
Healthcare AIAI Research +1
Yitu Technology
Shanghai, China
75%
3 shared categories
3 shared AI types
AI ResearchHealthcare AI +1